Position statement of the Latin American Dysphagia Society for the management of oropharyngeal and esophageal dysphagia during t
Frontiers | Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19
Investigation of MM-PBSA Rescoring of Docking Poses | Journal of Chemical Information and Modeling
Investigation of MM-PBSA Rescoring of Docking Poses | Journal of Chemical Information and Modeling
Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease | Scientific Reports
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors | ACS Medicinal Chemistry Letters
Frontiers | Extrafollicular Plasmablasts Present in the Acute Phase of Infections Express High Levels of PD-L1 and Are Able to Limit T Cell Response
Frontiers | Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19
Frontiers | Extrafollicular Plasmablasts Present in the Acute Phase of Infections Express High Levels of PD-L1 and Are Able to Limit T Cell Response
Position statement of the Latin American Dysphagia Society for the management of oropharyngeal and esophageal dysphagia during t
Items where Year is 2019 - SORA
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors | ACS Medicinal Chemistry Letters
Position statement of the Latin American Dysphagia Society for the management of oropharyngeal and esophageal dysphagia during the COVID-19 pandemic - ScienceDirect
Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery? | Journal of Medicinal Chemistry
IJERPH | Free Full-Text | A Saudi Arabian Public Health Perspective of Tuberculosis
Investigation of MM-PBSA Rescoring of Docking Poses | Journal of Chemical Information and Modeling
Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery? | Journal of Medicinal Chemistry
IJERPH | Free Full-Text | A Saudi Arabian Public Health Perspective of Tuberculosis
Frontiers | Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19
Frontiers | Extrafollicular Plasmablasts Present in the Acute Phase of Infections Express High Levels of PD-L1 and Are Able to Limit T Cell Response
